 |
Artbio
Last updated: July 30, 2025
CEO - Emanuele Ostuni
USA | Funding: $245M (+)
Website: https://artbio.com/
ARTBIO is a clinical-stage radiopharmaceutical biotechnology business that is working to create a new class of alpha radioligand medicines.
Website: https://artbio.com/
ARTBIO is a clinical-stage radiopharmaceutical biotechnology business that is working to create a new class of alpha radioligand medicines.
